Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 13Neoplasm Metastasis 10Carcinoma, Medullary 10Thyroid Neoplasms 5Lung Neoplasms 5Prostatic Neoplasms 3Neoplasms 3Adenocarcinoma 3Familial medullary thyroid carcinoma 2Colorectal Neoplasms 2Carcinoma, Squamous Cell 2Breast Neoplasms 2Recurrence 1Rectal Neoplasms 1Pleural Effusion 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Multiple Myeloma 1Mesothelioma 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Differentiated Thyroid Cancer 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Large Cell 1Carcinoma, Hepatocellular 1Carcinoma 1Biliary Tract Neoplasms 1Aggression 1Advanced Breast Cancer 1

Interventions

Bevacizumab 27Leucovorin 23Fluorouracil 22Oxaliplatin 17Irinotecan 15Cetuximab 14pembrolizumab 11IFL protocol 11Panitumumab 10Folfox protocol 10Capecitabine 10Gemcitabine 7adagrasib 5Cisplatin 5Carboplatin 5Ramucirumab 4Colonoscopy 4veliparib 3spartalizumab 3selpercatinib 3regorafenib 3labetuzumab 3durvalumab 3conatumumab 3cemiplimab 3Pemetrexed 3Paclitaxel 3HMPL-013 3Drug Therapy 35,11-methenyltetrahydrohomofolate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Colonic Neoplasms × vandetanib × Clear all
NCT00454116 2016-10-07

A Phase II, Double Blind Study of 2 Doses of ZACTIMAâ„¢(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients

Sanofi

Phase 2 Completed
106 enrolled 8 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡